Kirstie L Haywood1, Sophie Staniszewska, Sarah Chapman. 1. Royal College of Nursing Research Institute, School of Health and Social Studies, University of Warwick, Coventry CV4 7AL, UK. k.l.haywood@warwick.ac.uk
Abstract
PURPOSE: To review the quality and acceptability of condition-specific, domain-specific and generic multi-item patient-reported outcome measures (PROMs) used in the assessment of adults with chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME). METHODS: Systematic literature searches were made to identify PROMs. Quality and acceptability was assessed against an appraisal framework, which captured evidence of both the thoroughness and results of evaluations: evidence of measurement (reliability, validity, responsiveness, interpretability, data quality/precision) and practical properties (feasibility, patient acceptability), and the extent of active patient involvement was sought. RESULTS: A total of 11 CFS/ME-specific, 55 domain-specific and 11 generic measures were reviewed. With the exception of the generic SF-36, all measures had mostly limited evidence of measurement and/or practical properties. Patient involvement was poorly reported and often cursory. CONCLUSIONS: The quality and acceptability of reviewed PROMs is limited, and recommendations for patient-reported assessment are difficult. Significant methodological and quality issues in PROM development/evaluation were identified by the appraisal framework, which must be addressed in future research. Clear discrepancies exist between what is measured in research and how patients define their experience of CFS/ME. Future PROM development/evaluation must seek to involve patients more collaboratively to measure outcomes of importance using relevant and credible methods of assessment.
PURPOSE: To review the quality and acceptability of condition-specific, domain-specific and generic multi-item patient-reported outcome measures (PROMs) used in the assessment of adults with chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME). METHODS: Systematic literature searches were made to identify PROMs. Quality and acceptability was assessed against an appraisal framework, which captured evidence of both the thoroughness and results of evaluations: evidence of measurement (reliability, validity, responsiveness, interpretability, data quality/precision) and practical properties (feasibility, patient acceptability), and the extent of active patient involvement was sought. RESULTS: A total of 11 CFS/ME-specific, 55 domain-specific and 11 generic measures were reviewed. With the exception of the generic SF-36, all measures had mostly limited evidence of measurement and/or practical properties. Patient involvement was poorly reported and often cursory. CONCLUSIONS: The quality and acceptability of reviewed PROMs is limited, and recommendations for patient-reported assessment are difficult. Significant methodological and quality issues in PROM development/evaluation were identified by the appraisal framework, which must be addressed in future research. Clear discrepancies exist between what is measured in research and how patients define their experience of CFS/ME. Future PROM development/evaluation must seek to involve patients more collaboratively to measure outcomes of importance using relevant and credible methods of assessment.
Authors: Neil Aaronson; Jordi Alonso; Audrey Burnam; Kathleen N Lohr; Donald L Patrick; Edward Perrin; Ruth E Stein Journal: Qual Life Res Date: 2002-05 Impact factor: 4.147
Authors: A L Komaroff; L R Fagioli; T H Doolittle; B Gandek; M A Gleit; R T Guerriero; R J Kornish; N C Ware; J E Ware; D W Bates Journal: Am J Med Date: 1996-09 Impact factor: 4.965
Authors: Gordon H Guyatt; Carol Estwing Ferrans; Michele Y Halyard; Dennis A Revicki; Tara L Symonds; Claudette G Varricchio; Anna Kotzeva; Jose M Valderas; Jordi Alonso; Jordi L Alonso Journal: Mayo Clin Proc Date: 2007-10 Impact factor: 7.616
Authors: C B Terwee; L D Roorda; H C W de Vet; J Dekker; R Westhovens; J van Leeuwen; D Cella; H Correia; B Arnold; B Perez; M Boers Journal: Qual Life Res Date: 2014-01-09 Impact factor: 4.147
Authors: Kyle W Murdock; Xin Shelley Wang; Qiuling Shi; Charles S Cleeland; Christopher P Fagundes; Suzanne D Vernon Journal: Qual Life Res Date: 2016-09-06 Impact factor: 4.147
Authors: Geeske Peeters; Anna L Barker; Jason Talevski; Ilana Ackerman; Darshini R Ayton; Christopher Reid; Sue M Evans; Johannes U Stoelwinder; John J McNeil Journal: Qual Life Res Date: 2018-01-29 Impact factor: 4.147
Authors: Kirstie Haywood; Jo Brett; Sam Salek; Nancy Marlett; Colin Penman; Svetlana Shklarov; Colleen Norris; Maria Jose Santana; Sophie Staniszewska Journal: Qual Life Res Date: 2014-09-07 Impact factor: 4.147